8-K 1 v185930_8k.htm Unassociated Document


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.  20549

FORM 8-K
CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): May 19, 2010

GENVEC, INC.
(Exact name of registrant as specified in its charter)

Delaware
0-24469
23-2705690
(State or other jurisdiction
(Commission
(IRS Employer
of Incorporation)
File Number)
Identification No.)

65 West Watkins Mill Road, Gaithersburg, Maryland
20878
(Address of principal executive offices)
(Zip Code)


Registrant’s telephone number, including area code: (240) 632 0740
_______________________________
(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))


 
 
 
 
INFORMATION TO BE INCLUDED IN THE REPORT

Section 5 – Corporate Governance and Management

Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On May 19, 2010, Mark O. Thornton, M.D., M.P.H., Ph.D., Senior Vice President, Product Development for GenVec, Inc. (the “Company”), informed the Company that he intends to resign from the Company effective May 23, 2010.

On May 19, 2010, the Company filed a press release announcing the resignation of Dr. Thornton. A copy of the press release is attached to this current report as Exhibit 99.1 and is incorporated herein by reference.

Section 9 – Financial Statements and Exhibits

Item 9.01 
Financial Statements and Exhibits

(d)  Exhibits

99.1           GenVec, Inc. Press Release Issued on May 19, 2010
 
 
 
 
 
SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
  GENVEC, INC.  
       
Date: May 19, 2010  
By:
/s/ Douglas J. Swirsky  
    Douglas J. Swirsky  
    Senior Vice President, Chief Financial Officer, Treasurer and Corporate Secretary  
       
 
 
 
 
 
 
 
 
EXHIBIT INDEX
 

Exhibit                                                                Description

99.1                                GenVec, Inc. Press Release Issued on May 19, 2010